Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relugolix versus leuprorelin in female patients
jRCT2080224650Phase 3Completed
- Start
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of tissue-plasminogen activator (2 arms). Started Apr 2019; status: completed.
02
Drugs
tissue-plasminogen activator
Beyond the preview
Go deeper on jRCT2080224650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224650.